Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021
Neuroepidemiology · 19.12.2025 · 1-12
DOI: 10.1159/000549854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, online erschienen am 19.12.2025. Verfasst von Meiling Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cardiovascular Epidemiology, Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Ac…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Driven by population ageing, the burden of Alzheimer’s disease and other dementias (ADOD) continues to rise. A comprehensive assessment of the ADOD burden at global, regional, and national levels is critical for public health.
Methods
Based on the Global Burden of Disease Study 2021, we assessed the ADOD burden. Temporal trends were analysed using Joinpoint regression; inequalities among countries were evaluated via Lorenz curves; and future trends were projected employing an age-period-cohort model.
Results
In 2021, the age-standardised rates for ADOD were 694.01 (95% uncertainty intervals [UIs]: 602.88 to 794.08) for prevalence, 119.76 (95% UI: 104.96 to 135.89) for incidence, and 481.70 (95% UI: 228.79 to 1,023.96) for disability-adjusted life years (DALYs). Females exhibited a higher ADOD burden than males across all age groups, with an age-standardised prevalence rate of 769.94 (95% UI: 670.71 to 877.57) in females compared to 589.47 (95% UI: 507.48 to 678.79) in males. The slope inequality index of crude DALY rate increased from 315.23 (95% confidence intervals [CIs]: 310.43 to 437.87) in 1990 to 758.29 (95% CI: 692.48 to 908.29) in 2021 at the country level. The Lorenz curves for the crude DALY rate of ADOD in 1990 and 2021 lay below the equality line, indicating a higher burden among countries and territories with a higher socio-demographic index (SDI) ranking. By 2046, global prevalence is projected to reach 124.89 million, a 119.67% increase from 2021.
Conclusion
The ADOD burden has increased globally, with significant regional disparities. Urgent action is required to prevent ADOD, especially among females and in high-SDI regions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Cardiovascular Epidemiology, Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College/National Ce…
- Qingdao Municipal Hospital, Qingdao, China.
- Peking University People's Hospital, Qingdao, China.
- Women and Children's Hospital, Qingdao University, Qingdao, China.
- Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA.
- Department of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Zitieren
APA
Hu, M., Wang, T., Song, J., Liu, N., Zeng, Y., Hu, D., Guo, Y., Chang, J., & Lin, Z. (2025). Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021. Neuroepidemiology, 1-12. https://doi.org/10.1159/000549854
Vancouver
Hu M, Wang T, Song J, Liu N, Zeng Y, Hu D, et al. Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021. Neuroepidemiology. 2025:1-12. doi:10.1159/000549854
BibTeX
@article{Hu2025,
author = {Hu, Meiling and Wang, Tongyun and Song, Jing and Liu, Ningrui and Zeng, Yuhong and Hu, Danqing and Guo, Yang and Chang, Jie and Lin, Zhennan},
title = {Global, Regional, and National Disparities in the Burden of Alzheimer’s Disease and Other Dementias, 1990–2021},
journal = {Neuroepidemiology},
year = {2025},
pages = {1--12},
doi = {10.1159/000549854}
}
EUVIMED